Skip to content
PsiloAtlas
All states and countries

Legal status

New Zealand

Individual approval for clinical psychedelic treatmentFAQ →Bill tracker →Español →Providers and retreats in New Zealand →Reviewed October 2026

What psychedelic access is allowed in New Zealand?

Individual approval for clinical psychedelic treatment. Access depends on the substance and setting; this is not blanket permission to possess, buy or sell psychedelics.

Official source: Approval to prescribe, supply and administer psychedelics →

Psilocybin remains a Class A controlled drug in New Zealand. Medical practitioners may apply to Medsafe for individual approval under regulation 22 to prescribe, supply and administer psychedelics for a defined clinical purpose outside research. The first announced psilocybin approval covered treatment-resistant depression. This is not general prescribing permission or legal retreat access.

Current law

Misuse of Drugs Regulations 1977, regulation 22

  • Individual practitioners need approval for a defined clinical purpose
  • Psilocybin remains Class A and is not an approved medicine
  • The June 2025 announcement described an individual approval, not general access

Providers and their documented services

2 listed

Advance Aotearoa

Auckland, Auckland

Listed, not verified

Documented services

TMS and ketamine therapy

Sources

Full profile →

South Island Ketamine Clinic

Christchurch, Canterbury

Listed, not verified

Documented services

Ketamine consultations and treatment

Sources

Full profile →